Literature DB >> 18996902

Simultaneous absence of surfactant proteins A and D increases lung inflammation and injury after allogeneic HSCT in mice.

Kendra Gram1, Shuxia Yang, Marie Steiner, Arif Somani, Samuel Hawgood, Bruce R Blazar, Angela Panoskaltsis-Mortari, Imad Y Haddad.   

Abstract

The relative contributions of the hydrophilic surfactant proteins (SP)-A and -D to early inflammatory responses associated with lung dysfunction after experimental allogeneic hematopoietic stem cell transplantation (HSCT) were investigated. We hypothesized that the absence of SP-A and SP-D would exaggerate allogeneic T cell-dependent inflammation and exacerbate lung injury. Wild-type, SP-D-deficient (SP-D(-/-)), and SP-A and -D double knockout (SP-A/D(-/-)) C57BL/6 mice were lethally conditioned with cyclophosphamide and total body irradiation and given allogeneic bone marrow plus donor spleen T cells, simulating clinical HSCT regimens. On day 7, after HSCT, permeability edema progressively increased in SP-D(-/-) and SP-A/D(-/-) mice. Allogeneic T cell-dependent inflammatory responses were also increased in SP-D(-/-) and SP-A/D(-/-) mice, but the altered mediators of inflammation were not identical. Compared with wild-type, bronchoalveolar lavage fluid (BALF) levels of nitrite plus nitrate, GM-CSF, and MCP-1, but not TNF-alpha and IFN-gamma, were higher in SP-D-deficient mice before and after HSCT. In SP-A/D(-/-) mice, day 7 post-HSCT BALF levels of TNF-alpha and IFN-gamma, in addition to nitrite plus nitrate and MCP-1, were higher compared with mice lacking SP-D alone. After HSCT, both SP-A and SP-D exhibited anti-inflammatory lung-protective functions that were not completely redundant in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18996902      PMCID: PMC2643990          DOI: 10.1152/ajplung.90253.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  39 in total

1.  GM-CSF mediates alveolar macrophage proliferation and type II cell hypertrophy in SP-D gene-targeted mice.

Authors:  S Hawgood; J Akiyama; C Brown; L Allen; G Li; F R Poulain
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-06       Impact factor: 5.464

2.  Human surfactant protein a suppresses T cell-dependent inflammation and attenuates the manifestations of idiopathic pneumonia syndrome in mice.

Authors:  S Yang; C Milla; A Panoskaltsis-Mortari; D H Ingbar; B R Blazar; I Y Haddad
Journal:  Am J Respir Cell Mol Biol       Date:  2001-05       Impact factor: 6.914

3.  Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways.

Authors:  M Yoshida; T R Korfhagen; J A Whitsett
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

4.  Tolerance of SP-A-deficient mice to hyperoxia or exercise.

Authors:  M Ikegami; A H Jobe; J Whitsett; T Korfhagen
Journal:  J Appl Physiol (1985)       Date:  2000-08

5.  Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung.

Authors:  A M LeVine; J A Whitsett; J A Gwozdz; T R Richardson; J H Fisher; M S Burhans; T R Korfhagen
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

6.  The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A.

Authors:  Philip O'Reilly; Judy M Hickman-Davis; Philip McArdle; K Randall Young; Sadis Matalon
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

7.  Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice.

Authors:  Elena N Atochina; Andrew J Gow; James M Beck; Angela Haczku; Adam Inch; Helchem Kadire; Yaniv Tomer; Christine Davis; Angela M Preston; Francis Poulain; Samuel Hawgood; Michael F Beers
Journal:  J Infect Dis       Date:  2004-03-30       Impact factor: 5.226

8.  Surfactant protein A decreases lung injury and mortality after murine marrow transplantation.

Authors:  Shuxia Yang; Carlos Milla; Angela Panoskaltsis-Mortari; Samuel Hawgood; Bruce R Blazar; Imad Y Haddad
Journal:  Am J Respir Cell Mol Biol       Date:  2002-09       Impact factor: 6.914

9.  Lymphocyte activation in the lungs of SP-D null mice.

Authors:  James H Fisher; Jaque Larson; Carlyne Cool; Steve W Dow
Journal:  Am J Respir Cell Mol Biol       Date:  2002-07       Impact factor: 6.914

10.  Surfactant protein D reduces alveolar macrophage apoptosis in vivo.

Authors:  Howard Clark; Nades Palaniyar; Peter Strong; Jess Edmondson; Samuel Hawgood; Kenneth B M Reid
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

View more
  4 in total

1.  Novel role for surfactant protein A in gastrointestinal graft-versus-host disease.

Authors:  Kymberly M Gowdy; Diana M Cardona; Julia L Nugent; Charles Giamberardino; Joseph M Thomas; Sambuddho Mukherjee; Sambudho Mukherjee; Tereza Martinu; W Michael Foster; Scott E Plevy; Amy M Pastva; Jo Rae Wright; Scott M Palmer
Journal:  J Immunol       Date:  2012-04-16       Impact factor: 5.422

2.  Innate immunity of surfactant proteins A and D in urinary tract infection with uropathogenic Escherichia coli.

Authors:  Fengqi Hu; Guohua Ding; Zhiyong Zhang; Louis A Gatto; Samuel Hawgood; Francis R Poulain; Robert N Cooney; Guirong Wang
Journal:  Innate Immun       Date:  2015-10-28       Impact factor: 2.680

3.  Effect of irradiation/bone marrow transplantation on alveolar epithelial type II cells is aggravated in surfactant protein D deficient mice.

Authors:  Christian Mühlfeld; Jens Madsen; Rose-Marie Mackay; Jan Philipp Schneider; Julia Schipke; Dennis Lutz; Bastian Birkelbach; Lars Knudsen; Marina Botto; Matthias Ochs; Howard Clark
Journal:  Histochem Cell Biol       Date:  2016-08-26       Impact factor: 4.304

Review 4.  Surfactant Protein D in Respiratory and Non-Respiratory Diseases.

Authors:  Grith L Sorensen
Journal:  Front Med (Lausanne)       Date:  2018-02-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.